Bristol

Eterna Therapeutics Appoints James Bristol, Ph.D., Pharmaceutical Research and Drug Discovery Veteran, to Board of Directors

Retrieved on: 
Wednesday, November 1, 2023

Bristol is a seasoned biopharmaceutical executive who has excelled as a corporate partner, board member, and strategic and technical advisor within our industry,” said Matt Angel, Ph.D., Chief Executive Officer and President of Eterna.

Key Points: 
  • Bristol is a seasoned biopharmaceutical executive who has excelled as a corporate partner, board member, and strategic and technical advisor within our industry,” said Matt Angel, Ph.D., Chief Executive Officer and President of Eterna.
  • Before that, he worked at Parke-Davis for 20 years, where he held positions of increasing responsibility in Chemistry and Drug Discovery and participated in collaboration oversight committees.
  • Early in his career, Dr. Bristol was a Principal Scientist at Schering-Plough, leading the gastrointestinal research program.
  • His drug discovery research has resulted in numerous publications, abstracts, and patents.

UK Government Invests £225m to Create UK’s Most Powerful AI Supercomputer With University of Bristol and Hewlett Packard Enterprise

Retrieved on: 
Wednesday, November 1, 2023

Hewlett Packard Enterprise (HPE) will build and deliver the new system with the next generation HPE Cray EX supercomputers and over 5,000 state-of-the-art NVIDIA GH200 superchips.

Key Points: 
  • Hewlett Packard Enterprise (HPE) will build and deliver the new system with the next generation HPE Cray EX supercomputers and over 5,000 state-of-the-art NVIDIA GH200 superchips.
  • Professor Simon McIntosh-Smith, Director of the Isambard National Research Facility at the University of Bristol, said: “Isambard-AI represents a huge leap forward for AI computational power in the UK.
  • We are proud to partner with the UK Government and the University of Bristol to give UK researchers and industry access to Europe's largest AI system for open science."
  • Bristol is one of the top UK universities for AI research and scientific computing.

Lucy Letby: child murder case highlights need to regulate managers and improve whistleblowing procedures

Retrieved on: 
Friday, August 25, 2023

Two medical consultants, Dr Stephen Brearey and Dr Ravi Jayaram, both raised concerns about unexplained infant deaths as early as July 2015.

Key Points: 
  • Two medical consultants, Dr Stephen Brearey and Dr Ravi Jayaram, both raised concerns about unexplained infant deaths as early as July 2015.
  • Common sense would dictate that if a senior doctor raised concerns with managers, even informally, it would be taken seriously.
  • This highlights an urgent need to change the structure of the NHS to ensure managers and executives are held to account for the decisions they make.

Refusal to act

    • In hospitals such as the Countess of Chester, most routine decisions are made by middle management.
    • Brearey and Jayaram suggested that executives were attempting to minimise any reputational damage to the unit and, by extension, the hospital.
    • The decisions of hospital executives will be investigated as part of a public inquiry.

Freedom to Speak Up

    • This is what led to the Freedom to Speak Up review, which investigated how organisations dealt with concerns raised by NHS staff.
    • The results of the report led to the Freedom to Speak Up policy, which provides guidance for NHS staff on how they can raise patient safety concerns.
    • A Freedom to Speak Up Guardian is also now present in every NHS Trust to ensure issues raised are responded to.
    • Even with the Freedom to Speak Up Policy, the British Medical Association reports that staff are still being victimised for raising concerns.
    • Clearly, the policy needs to be improved and legislation passed that would protect staff from dismissal if they do speak up.

Perimeter Medical Imaging AI Announces the Engagement of Bristol Capital Ltd. for Investor Relations Services

Retrieved on: 
Wednesday, August 16, 2023

TORONTO and DALLAS, Aug. 16, 2023 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – announced that it has retained Bristol Capital Ltd. ("Bristol") a leading investor relations firm servicing Canadian and US micro-cap and small-cap companies across international markets, to provide investor relations and communication services.

Key Points: 
  • TORONTO and DALLAS, Aug. 16, 2023 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – announced that it has retained Bristol Capital Ltd. ("Bristol") a leading investor relations firm servicing Canadian and US micro-cap and small-cap companies across international markets, to provide investor relations and communication services.
  • Adrian Mendes, Perimeter's Chief Executive Officer stated, "We are pleased to retain Bristol as part of our commitment to enhance our investor outreach efforts to engage with existing investors and grow our shareholder base.
  • Bristol will be paid a monthly fee of up to CAD$14,000, plus applicable taxes, based on the services to be provided during the applicable month, such fee payable by Perimeter within 30 days of receipt of invoice.
  • The appointment of Bristol remains subject to regulatory acceptance of applicable filings with the TSXV.

Cumulus Neuroscience Announces Research Collaboration with the Universities of Bath and Bristol on Development of Breakthrough Test for Early Detection of Alzheimer's Dementia

Retrieved on: 
Thursday, July 13, 2023

Dr. Liz Coulthard , Associate Professor in Dementia Neurology at the University of Bristol and neurologist at North Bristol National Health Service (NHS) Trust , is the project co-lead.

Key Points: 
  • Dr. Liz Coulthard , Associate Professor in Dementia Neurology at the University of Bristol and neurologist at North Bristol National Health Service (NHS) Trust , is the project co-lead.
  • Importantly, as a passive test, performance is not impacted by anxiety level, education level or language.
  • They have also demonstrated that this response changes when a person develops dementia, offering hope for its potential as a breakthrough for earlier diagnosis.
  • We are honored to partner with the Universities of Bath and Bristol on this important study."

Cumulus Neuroscience Announces Research Collaboration with the Universities of Bath and Bristol on Development of Breakthrough Test for Early Detection of Alzheimer's Dementia

Retrieved on: 
Thursday, July 13, 2023

Dr. Liz Coulthard , Associate Professor in Dementia Neurology at the University of Bristol and neurologist at North Bristol National Health Service (NHS) Trust , is the project co-lead.

Key Points: 
  • Dr. Liz Coulthard , Associate Professor in Dementia Neurology at the University of Bristol and neurologist at North Bristol National Health Service (NHS) Trust , is the project co-lead.
  • Importantly, as a passive test, performance is not impacted by anxiety level, education level or language.
  • They have also demonstrated that this response changes when a person develops dementia, offering hope for its potential as a breakthrough for earlier diagnosis.
  • We are honored to partner with the Universities of Bath and Bristol on this important study."

Vista Outdoor Foundation Elects Diane Bristol of Simms as Board President

Retrieved on: 
Thursday, June 22, 2023

The Vista Outdoor Foundation (the “Foundation”), the philanthropic partner of Vista Outdoor Inc. (NYSE: VSTO), announced that its Board of Directors has unanimously elected Diane Bristol as Board President.

Key Points: 
  • The Vista Outdoor Foundation (the “Foundation”), the philanthropic partner of Vista Outdoor Inc. (NYSE: VSTO), announced that its Board of Directors has unanimously elected Diane Bristol as Board President.
  • Bristol serves as Vice President of Culture & Community for Vista Outdoor brand Simms Fishing Products.
  • View the full release here: https://www.businesswire.com/news/home/20230622313339/en/
    The Vista Outdoor Foundation, the philanthropic partner of Vista Outdoor Inc., announced that its Board of Directors has unanimously elected Diane Bristol as Board President.
  • Bristol serves as Vice President of Culture & Community for Vista Outdoor brand Simms Fishing Products.

Up And Coming Cyber Security Specialist Stripe OLT, Achieve Microsoft Security Solutions Partner Status

Retrieved on: 
Tuesday, June 20, 2023

LONDON, June 20, 2023 /PRNewswire/ -- Stripe OLT, the Bristol & London based Cyber Security & IT provider has attained their second Microsoft designation, officially achieving their Security Solutions Partner status, only eight weeks after achieving their Modern Work Solutions Partner designation.

Key Points: 
  • LONDON, June 20, 2023 /PRNewswire/ -- Stripe OLT, the Bristol & London based Cyber Security & IT provider has attained their second Microsoft designation, officially achieving their Security Solutions Partner status, only eight weeks after achieving their Modern Work Solutions Partner designation.
  • For every Microsoft partner, this is considered a highly coveted certification that demonstrates leading capabilities within the Microsoft cyber security stack.
  • He continues: We are immensely proud to receive our security partner status, which serves as a validation of our deeply technical skillset.
  • Additionally offering a variety of managed IT security plans, through their award-winning 24/7 Managed Cyber Security Operations Centre .

Nomad Temporary Housing Is Awarded the BristolNet Moment of Truth Award from Bristol Global Mobility

Retrieved on: 
Thursday, June 15, 2023

SAN DIEGO, June 15, 2023 /PRNewswire/ -- Nomad Temporary Housing is delighted to share that it has earned the BristolNet Moment of Truth Award from Bristol Global Mobility.

Key Points: 
  • SAN DIEGO, June 15, 2023 /PRNewswire/ -- Nomad Temporary Housing is delighted to share that it has earned the BristolNet Moment of Truth Award from Bristol Global Mobility.
  • This honor is in recognition of a moment in time in which Nomad truly went above and beyond the normal call of duty in the name of stellar customer service.
  • A longtime strategic partner for Bristol Global Mobility, Nomad has consistently exhibited a client first mentality.
  • The acute focus that we all have on the client is illustrated daily by the service delivery we provide."

Green Thumb to Open RISE Bristol, its 80th Retail Location in the Nation, On May 24th

Retrieved on: 
Tuesday, May 23, 2023

CHICAGO and VANCOUVER, British Columbia, May 23, 2023 (GLOBE NEWSWIRE) -- RISE Dispensaries , a rapidly growing cannabis retail chain owned by Green Thumb Industries Inc. (“Green Thumb” or “the Company”) (CSE: GTII) (OTCQX: GTBIF), today announced that RISE Bristol, the Company’s fifth location in Virginia and 80th nationwide, will open on Wednesday, May 24th.

Key Points: 
  • CHICAGO and VANCOUVER, British Columbia, May 23, 2023 (GLOBE NEWSWIRE) -- RISE Dispensaries , a rapidly growing cannabis retail chain owned by Green Thumb Industries Inc. (“Green Thumb” or “the Company”) (CSE: GTII) (OTCQX: GTBIF), today announced that RISE Bristol, the Company’s fifth location in Virginia and 80th nationwide, will open on Wednesday, May 24th.
  • “We are thrilled to open RISE Bristol in Virginia, further expanding Green Thumb's commitment to providing access to premium cannabis brands,” said Green Thumb Founder, Chairman and Chief Executive Officer Ben Kovler.
  • “RISE Bristol will serve as a place of well-being, compassion and support for medical cannabis patients in Virginia.
  • All RISE dispensaries in Virginia have licensed pharmacists in store to help medical patients with product selection; walk-in consultation requests are welcome.